Glucose Health, Inc. Appoints Former Celsius CEO Gerry David to Strategic Advisory Board
Glucose Health, Inc. appointed Gerry David as the chairman of its Strategic Advisory Board of Directors on Thursday, June 4, 2026. In this new role, David will oversee the company’s strategic initiatives and provide guidance to the board regarding corporate development.
David brings experience from his previous tenure as the president and chief executive officer of Celsius Holdings, Inc., where he led the company’s growth and market expansion. Glucose Health, Inc. intends to utilize his background in the consumer goods and health sectors to support its ongoing business operations. The company confirmed the appointment as part of its efforts to strengthen its advisory leadership team.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: June 4, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]






